USFDA conducts inspection at Ipca Laboratories’ APIs manufacturing facility at Tarapur

05 Dec 2025 Evaluate

The United States Food and Drug Administration (USFDA) has conducted the inspection at Ipca Laboratories’ Active Pharmaceutical Ingredients (APIs) manufacturing facility situated at Tarapur (Palghar-Maharashtra) from December 1, 2025 to December 5, 2025. At the conclusion of the inspection, USFDA has issued a Form 483 with 3 observations.

The company will submit its comprehensive response on these observations to the USFDA within the stipulated time and shall work closely with the agency to resolve these issues at the earliest. The company takes the quality and compliance issues with utmost importance and remains committed to maintain the highest standards of quality and compliance across all its manufacturing facilities.

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations.


Ipca Laboratories Share Price

1485.60 8.35 (0.57%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×